Back to Search
Start Over
Therapeutic effect of ginkgetin on smoke-induced airway inflammation by down-regulating the c/EBPβ signaling pathway and CCL2 expression.
- Source :
-
Journal of ethnopharmacology [J Ethnopharmacol] 2024 Sep 15; Vol. 331, pp. 118284. Date of Electronic Publication: 2024 May 10. - Publication Year :
- 2024
-
Abstract
- Ethnopharmacological Relevance: Ginkgo biloba leaf and seed have been traditionally used in ancient China for the treatment of cough and asthma. However, there is limited literature available on the anti-COPD effects and mechanisms of Ginkgo biloba.<br />Aims of the Study: The aim of this study was to comprehensively investigate the therapeutic potential of ginkgo extracts in COPD through a combination of in vivo and in vitro functional experiments. Transcriptomic analyses were also employed to uncover novel molecular mechanisms underlying the therapeutic effects of ginkgetin in COPD.<br />Materials and Methods: The therapeutic efficacy of ginkgo extracts was assessed in a COPD model. The anti-inflammatory effects of ginkgetin and its underlying molecular mechanisms were examined in A549 cells treated with cigarette smoke extract (CSE). Additionally, transcriptomic analyses were conducted to identify novel molecular pathways influenced by ginkgetin. These findings were further validated using quantitative real-time polymerase chain reaction (qPCR) and Western blot techniques.<br />Results: The ethyl acetate extract of Ginkgo biloba L. seeds and ginkgetin treatment significantly reduced cytokine production in COPD mice. Following drug administration, lung function improved in different groups. The transcriptome data strongly supports the inhibitory effect of ginkgetin on CSE-induced inflammation through the downregulation of the c/EBPβ signaling pathway and subsequent inhibition of CCL2 expression.<br />Conclusion: Our results demonstrate that ginkgetin, one of the biflavones found in Ginkgo biloba, exhibits inhibitory effects on smoke-induced airway inflammation. This effect is achieved through the downregulation of the c/EBPβ signaling pathway and the reduction of CCL2 expression.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Humans
Mice
Male
Plant Extracts pharmacology
Plant Extracts therapeutic use
Smoke adverse effects
Anti-Inflammatory Agents pharmacology
Anti-Inflammatory Agents therapeutic use
A549 Cells
Mice, Inbred C57BL
Disease Models, Animal
Lung drug effects
Lung metabolism
Lung pathology
Ginkgo Extract
Pulmonary Disease, Chronic Obstructive drug therapy
Biflavonoids pharmacology
Biflavonoids therapeutic use
Signal Transduction drug effects
Ginkgo biloba chemistry
Down-Regulation drug effects
Chemokine CCL2 genetics
Chemokine CCL2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7573
- Volume :
- 331
- Database :
- MEDLINE
- Journal :
- Journal of ethnopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 38735420
- Full Text :
- https://doi.org/10.1016/j.jep.2024.118284